International Supply. Orange will be responsible for shipping and exporting the Products to the Delivery Locations according to Incoterms agreed between the Parties, as described in Clause 1.4.2.3 (Incoterms). Customer will appoint the entity acting as IOR (either Customer, its local Affiliate, or the consignee named by Customer in the importing country), and such entity will be responsible for performing the importation of Products. As importer of Products, such IOR will be liable for all administrative and import customs formalities as required by the Trade Control Rules in the importing countries, including without limitation (a) paying all applicable import duties and taxes, and (b) obtaining any Permits required for import.
International Supply. The parties recognize that the Product is presently approved for marketing in the United States and Canada, and that Berlex will be marketing the Product in Canada as well as the United States. In addition, Berlex intends to market the Product in other countries of North America and South America as marketing approvals are obtained in such countries. DuPont agrees to cooperate with Berlex and Cytogen as is reasonable in the circumstances in respect to packaging and labeling the Product for distribution in countries other than the United States. DuPont, Berlex and Cytogen will cooperate in providing documentation required by governmental authorities relating to the export of the Product from the United States and the import of the Product into countries other than the United States. Berlex shall promptly reimburse DuPont for any and all incremental costs incurred by DuPont under this Section 2.14.
International Supply. The parties recognize that the Product is presently approved for marketing in the Territory. In addition, Cytogen intends to market the Product in other countries of North America and South America as the marketing approvals that Cytogen is pursuing at its sole cost and expense are obtained in such countries, at which point, the parties shall discuss whether the Territory should be expanded to include such countries. After the marketing approvals for such additional countries of North America and South America are obtained and the Territory has been expanded by mutual agreement of the parties, BMS shall cooperate with Cytogen as is reasonable in the circumstances in respect to packaging and labeling the Product for distribution in countries other than the Territory. BMS and Cytogen will cooperate in providing documentation required by governmental authorities relating to the export of the Product from the United States and the import of the Product into countries other than the United States. Cytogen shall promptly reimburse BMS for any and all incremental costs incurred by BMS under this Section 2.13.
